Pink Sheet Podcast: Kids’ COVID-19 Vaccines, Merck Shares COVID Pill, Accelerated Approval Problems

Pink Sheet reporters and editors discuss the issues that could arise when the COVID-19 vaccines are given to children age 5 to 11, Merck’s agreement to share the license for its proposed oral COVID-19 treatment, and problems for a sponsor blocked by an accelerated approval conversion to full approval.